V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10446562 | 10033906 | 1.76 | null | Adjuvant (A) | 2017-10-23 | 2017-11-12 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 101321232 |
| 10446564 | 10033907 | 1.86 | 88.3 | Curative (C) | 2017-01-21 | 2017-01-31 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101607245 |
| 10446565 | 10033908 | 1.58 | 93 | null | 2016-08-20 | 2016-09-09 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100267790 |
| 10446569 | 10033909 | 1.76 | 82.4 | Palliative (P) | null | 2017-11-21 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100297735 |
| 10446570 | 10033910 | 1.69 | 0 | Palliative (P) | 2020-05-12 | 2020-05-30 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100295282 |
| 10446574 | 10033911 | 1.82 | 76.7 | Palliative (P) | 2018-03-21 | 2018-04-29 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100967400 |
| 10446593 | 10033912 | 1.74 | 124 | Curative (C) | 2019-07-04 | 2019-07-20 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101437243 |
| 10446602 | 10033913 | 1.52 | 116.6 | Curative (C) | 2018-06-08 | 2018-06-20 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100740693 |
| 10446638 | 10033914 | 1.6 | 66 | null | 2022-03-15 | 2022-04-01 | Capecitabine + Oxaliplatin 14day | 02 | null | PEMBROLIZUMAB | 101573274 |
| 10446647 | 10033915 | 1.66 | 85.5 | Palliative (P) | 2019-12-21 | 2019-12-30 | Rituximab | 02 | N | RITUXIMAB | 100080646 |
| 10446649 | 10033916 | 1.8 | 74.2 | null | 2015-04-22 | 2015-04-22 | Capecitabine + Oxaliplatin 14day | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101605979 |
| 10446695 | 10033917 | 1.7 | 89 | Curative (C) | 2021-02-27 | 2021-03-29 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101058643 |
| 10446705 | 10033918 | 1.59 | 79.4 | Adjuvant (A) | 2017-05-03 | 2017-05-06 | Capecitabine + Oxaliplatin 14day | 02 | N | DOCETAXEL | 101801337 |
| 10446709 | 10033919 | null | null | Neo-adjuvant (N) | 2021-08-15 | 2021-09-21 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100713431 |
| 10446724 | 10033920 | null | 56.1 | Disease modification (D) | 2019-11-27 | 2019-12-15 | Docetaxel | 02 | null | DOCETAXEL | 101774646 |
| 10446725 | 10033921 | 1.83 | 51.8 | null | 2021-12-15 | 2021-12-29 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101754994 |
| 10446751 | 10033922 | 1.73 | 95.7 | Palliative (P) | 2018-07-24 | 2018-08-24 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100293999 |
| 10446796 | 10033923 | null | null | null | 2022-01-15 | 2022-02-05 | Rituximab | 02 | null | RITUXIMAB | 101501405 |
| 10446808 | 10033924 | 1.75 | 106 | Palliative (P) | 2019-10-14 | 2019-10-15 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101493167 |
| 10446809 | 10033925 | 1.68 | 77.6 | Palliative (P) | 2018-09-01 | 2018-09-01 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100892444 |
| 10446821 | 10033926 | 1.73 | 68.9 | Palliative (P) | 2019-04-05 | 2019-04-19 | Capecitabine | 02 | N | CAPECITABINE | 101128228 |
| 10446827 | 10033927 | 1.75 | null | Palliative (P) | 2020-02-08 | 2020-04-04 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100973496 |
| 10446846 | 10033928 | 1.75 | 78.5 | null | 2017-02-01 | 2017-02-01 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101417859 |
| 10446848 | 10033929 | 1.82 | 87.8 | Adjuvant (A) | 2018-08-03 | 2018-08-25 | Capecitabine + Oxaliplatin 14day | N | N | CAPECITABINE + OXALIPLATIN | 101118688 |
| 10446853 | 10033930 | 1.75 | 84 | Curative (C) | 2019-08-06 | 2019-09-13 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100542122 |
| 10446854 | 10033931 | 1.49 | 110 | Neo-adjuvant (N) | null | 2019-11-09 | Capecitabine + Oxaliplatin 21day | 02 | null | RITUXIMAB | 100788276 |
| 10446860 | 10033932 | 1.65 | 96 | Curative (C) | 2020-02-29 | 2020-03-08 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101794249 |
| 10446872 | 10033933 | 1.75 | 90.5 | Palliative (P) | 2018-03-27 | 2018-04-16 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101606565 |
| 10446877 | 10033934 | 1.65 | 78 | Palliative (P) | 2018-03-14 | 2018-03-30 | Capecitabine | 02 | N | CAPECITABINE | 101640484 |
| 10446878 | 10033935 | 1.58 | 91.3 | Curative (C) | 2016-10-14 | 2016-10-23 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 101131559 |
| 10446880 | 10033936 | 1.82 | 79.1 | Adjuvant (A) | 2015-03-27 | 2015-04-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101189253 |
| 10446896 | 10033937 | 1.62 | 73.8 | null | 2021-12-15 | 2021-12-15 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101824209 |
| 10446925 | 10033938 | 1.64 | 42 | Adjuvant (A) | 2018-10-06 | 2018-10-14 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100694436 |
| 10446946 | 10033939 | 1.57 | 86 | Palliative (P) | 2019-04-19 | 2019-05-01 | IBRUTINIB | 02 | N | IBRUTINIB | 101336238 |
| 10446958 | 10033940 | 1.52 | 89 | Palliative (P) | 2015-11-20 | 2015-12-16 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 101321974 |
| 10446966 | 10033941 | 1.88 | 71 | null | 2019-11-17 | 2019-12-02 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101712742 |
| 10447039 | 10033942 | 1.51 | 71 | Curative (C) | 2020-01-13 | 2020-01-13 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | RITUXIMAB | 101769735 |
| 10447060 | 10033943 | 1.49 | 81 | Palliative (P) | null | 2017-04-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100869184 |
| 10447066 | 10033944 | 1.82 | 104.9 | Palliative (P) | 2018-04-12 | 2018-04-24 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 100924659 |
| 10447068 | 10033945 | 1.72 | 45.4 | Curative (C) | 2019-02-05 | 2019-02-06 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100930228 |
| 10447085 | 10033946 | 1.78 | 40.4 | 03 | 2018-12-24 | 2018-12-29 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100062743 |
| 10447119 | 10033947 | 1.77 | 91 | 03 | 2018-06-23 | 2018-06-28 | CAPECITABINE + OXALIPLATIN | 02 | N | IBRUTINIB | 100749283 |
| 10447129 | 10033948 | 1.73 | 108.6 | Curative (C) | 2020-03-05 | 2020-03-24 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100971913 |
| 10447132 | 10033949 | 1.61 | 68.8 | null | 2020-09-14 | 2020-10-07 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100296537 |
| 10447137 | 10033950 | 1.7 | 100 | Palliative (P) | 2018-10-03 | 2018-10-10 | Rituximab | 02 | N | RITUXIMAB | 100697414 |
| 10447156 | 10033951 | 1.53 | null | Palliative (P) | 2020-07-05 | 2020-07-07 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100427891 |
| 10447160 | 10033952 | 1.81 | 77.6 | null | 2022-01-18 | 2022-01-18 | IBRUTINIB | 02 | null | IBRUTINIB | 100031836 |
| 10447178 | 10033953 | 1.63 | 81.2 | Adjuvant (A) | 2019-03-29 | 2019-03-29 | Rituximab | 02 | N | RITUXIMAB | 100503575 |
| 10447184 | 10033954 | 1.7 | 75 | null | 2019-09-20 | 2019-09-29 | Rituximab | 02 | null | RITUXIMAB | 101222238 |
| 10447189 | 10033955 | 1.62 | 88.4 | null | 2020-08-04 | 2020-08-15 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101808472 |